Please provide your email address to receive an email when new articles are posted on . The next new treatment for rheumatoid arthritis could come from the unlikeliest of sources. Researchers based at ...
Ra Pharmaceuticals Presents Pre-Clinical Data for Zilucoplan XR at the 6 th Annual Peptides Congress
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today presented pre-clinical data for an extended release (XR) formulation of zilucoplan at the 6 th Annual Peptides Congress, ...
Please provide your email address to receive an email when new articles are posted on . Methotrexate use at the pre-arthritis stage of symptoms and subclinical inflammation fails to prevent clinical ...
As a chronic condition, rheumatoid arthritis (RA) can't be cured, so treatment focuses on managing the disease and controlling its progression. Although current treatments help control RA symptoms in ...
A new therapeutic approach for rheumatoid arthritis (RA) could help prolong the time between flare-ups and even prevent the onset of the disease in at-risk patients. This is the promise of a new study ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Rheumatoid arthritis (RA) is currently diagnosed and treated ...
Studies designed to shed light on the prediction of rheumatoid arthritis (RA) are showing substantial promise -- not only for RA but a host of other rheumatic diseases. Rheumatology care professionals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results